Learn about the latest dosing guidance for avatrombopag now!

Avatrombopag is an oral thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adults with chronic liver disease requiring surgery. The following are dosing instructions for avatrombopag:

1.Drug Information: Avatrombopag is an oral medication used to increase platelet counts. Its main function is to promote the production and release of platelets in the bone marrow by stimulating the thrombopoietin receptor, thereby increasing the platelet count and reducing the risk of surgery-related bleeding.

2.Indications: Avatrombopag is indicated for adult patients with chronic liver disease, especially those requiring surgery, whose platelet counts are lower than normal and who are at risk of surgical bleeding.

3.Dosage: The recommended starting dose of avatrombopag is20mg, taken orally once daily. Physicians may adjust dosage based on the patient's individual condition and clinical response.

4.Dosing time: Avatrombopag is usually started days to weeks before surgery to ensure that the patient's platelet count reaches an adequate level, thereby reducing the risk of surgery-related bleeding. Your doctor may continue using it for a while after surgery, if needed.

5.How to take the drug: Avatrombopag should be swallowed whole, preferably after meals to reduce the occurrence of gastrointestinal adverse reactions.

6.Monitoring and adjustment: During the medication, doctors will regularly monitor the patient's platelet count and adjust the dose of avatrombopag as needed to ensure that the platelet count is within a safe range.

7.Adverse reactions: Common adverse reactions of avatrombopag include headache, nausea, diarrhea and other digestive system symptoms, as well as fatigue, dizziness and other adverse reactions. Patients should pay close attention to any adverse reactions during use and report to the doctor in time.

8.Contraindications: Avatrombopag is contraindicated in patients with a history of severe allergies or allergies to drug ingredients. In addition, it is not recommended for pregnant women, lactating women, and patients with severe liver damage.

9.Interactions with other drugs: During the use of avatrombopag, patients should avoid concurrent use with other drugs that may affect platelet function, such as aspirin, non-steroidal anti-inflammatory drugs, etc. Patients should consult their doctor when using other medications.

10.Pediatric Medication: The safety and effectiveness of avatrombopag in children have not yet been established, so its use in children is not recommended.

To sum up, avatrombopag is an oral thrombopoietin receptor agonist used to treat adult patients with chronic liver disease. Its medication guidance includes indications, dosage, medication time, medication mode, monitoring and adjustment, adverse reactions, contraindications, interactions with other drugs, etc. Patients should strictly follow the doctor's instructions during use and report any adverse reactions in a timely manner.